FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2594607607> ?p ?o ?g. }

• W2594607607 endingPage "S35" @default.
• W2594607607 startingPage "S30" @default.
• W2594607607 abstract "Antimicrobial resistance in pathogenic gram-negative bacteria is one of the most pressing challenges in the field of infectious diseases and is one of 4 key areas of unmet medical need identified by the Antibacterial Resistance Leadership Group (ARLG). The mission of the Gram-Negative Committee is to advance our knowledge of these challenging infections and implement studies to improve patient outcomes. Studies have fallen primarily into 2 broad categories: prospective cohort studies and interventional trials. Among the observational studies, CRACKLE (Consortium on Resistance Against Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae) has contributed seminal multicenter data describing risk factors and clinical outcomes of carbapenem-resistant Enterobacteriaceae (CRE) in sentinel US hospitals. Building on this success, CRACKLE II will expand the network to hospitals across the United States and Colombia. Similar protocols have been proposed to include Acinetobacter baumannii and Pseudomonas aeruginosa (SNAP and POP studies). In addition, the CREST study (Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplant Patients) has provided pivotal data on extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae and CRE carriage among solid organ transplant recipients to inform management of this vulnerable patient population. Two clinical trials to define novel ways of using an existing antibiotic, fosfomycin, to treat ESBL-producing Enterobacteriaceae (one that has completed enrollment and the other in late protocol development) will determine the clinical efficacy of fosfomycin as step-down oral therapy to treat complicated urinary tract infections. Additional clinical studies and trials using immunotherapeutic or newly approved agents are also in the planning stage, with the main goals of generating actionable data that will inform clinical decision making and facilitate development of new treatment options for highly resistant gram-negative bacterial infections." @default.
• W2594607607 created "2017-03-16" @default.
• W2594607607 creator A5000611736 @default.
• W2594607607 creator A5006534529 @default.
• W2594607607 creator A5010409085 @default.
• W2594607607 creator A5013718821 @default.
• W2594607607 creator A5024677215 @default.
• W2594607607 creator A5032938040 @default.
• W2594607607 creator A5034386514 @default.
• W2594607607 creator A5068286313 @default.
• W2594607607 creator A5085866405 @default.
• W2594607607 date "2017-03-02" @default.
• W2594607607 modified "2023-10-16" @default.
• W2594607607 title "Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group" @default.
• W2594607607 cites W1617706322 @default.
• W2594607607 cites W1870929680 @default.
• W2594607607 cites W1976159940 @default.
• W2594607607 cites W1986021215 @default.
• W2594607607 cites W2017404622 @default.
• W2594607607 cites W2102467528 @default.
• W2594607607 cites W2113898837 @default.
• W2594607607 cites W2114653497 @default.
• W2594607607 cites W2119292070 @default.
• W2594607607 cites W2120750073 @default.
• W2594607607 cites W2131640216 @default.
• W2594607607 cites W2134983258 @default.
• W2594607607 cites W2157660723 @default.
• W2594607607 cites W2181259101 @default.
• W2594607607 cites W2213076469 @default.
• W2594607607 cites W2253850614 @default.
• W2594607607 cites W2277352124 @default.
• W2594607607 cites W2392734635 @default.
• W2594607607 cites W2468793326 @default.
• W2594607607 cites W2540847854 @default.
• W2594607607 cites W2592141579 @default.
• W2594607607 cites W2593125028 @default.
• W2594607607 cites W2594349659 @default.
• W2594607607 doi "https://doi.org/10.1093/cid/ciw829" @default.
• W2594607607 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5850444" @default.
• W2594607607 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28350901" @default.
• W2594607607 hasPublicationYear "2017" @default.
• W2594607607 type Work @default.
• W2594607607 sameAs 2594607607 @default.
• W2594607607 citedByCount "109" @default.
• W2594607607 countsByYear W25946076072017 @default.
• W2594607607 countsByYear W25946076072018 @default.
• W2594607607 countsByYear W25946076072019 @default.
• W2594607607 countsByYear W25946076072020 @default.
• W2594607607 countsByYear W25946076072021 @default.
• W2594607607 countsByYear W25946076072022 @default.
• W2594607607 countsByYear W25946076072023 @default.
• W2594607607 crossrefType "journal-article" @default.
• W2594607607 hasAuthorship W2594607607A5000611736 @default.
• W2594607607 hasAuthorship W2594607607A5006534529 @default.
• W2594607607 hasAuthorship W2594607607A5010409085 @default.
• W2594607607 hasAuthorship W2594607607A5013718821 @default.
• W2594607607 hasAuthorship W2594607607A5024677215 @default.
• W2594607607 hasAuthorship W2594607607A5032938040 @default.
• W2594607607 hasAuthorship W2594607607A5034386514 @default.
• W2594607607 hasAuthorship W2594607607A5068286313 @default.
• W2594607607 hasAuthorship W2594607607A5085866405 @default.
• W2594607607 hasBestOaLocation W25946076071 @default.
• W2594607607 hasConcept C104317684 @default.
• W2594607607 hasConcept C126322002 @default.
• W2594607607 hasConcept C166888038 @default.
• W2594607607 hasConcept C177713679 @default.
• W2594607607 hasConcept C2775992322 @default.
• W2594607607 hasConcept C2776315533 @default.
• W2594607607 hasConcept C2777058267 @default.
• W2594607607 hasConcept C2777637488 @default.
• W2594607607 hasConcept C2778897966 @default.
• W2594607607 hasConcept C2908647359 @default.
• W2594607607 hasConcept C501593827 @default.
• W2594607607 hasConcept C523546767 @default.
• W2594607607 hasConcept C535046627 @default.
• W2594607607 hasConcept C54355233 @default.
• W2594607607 hasConcept C547475151 @default.
• W2594607607 hasConcept C55493867 @default.
• W2594607607 hasConcept C71924100 @default.
• W2594607607 hasConcept C86803240 @default.
• W2594607607 hasConcept C89423630 @default.
• W2594607607 hasConcept C94665300 @default.
• W2594607607 hasConcept C99454951 @default.
• W2594607607 hasConceptScore W2594607607C104317684 @default.
• W2594607607 hasConceptScore W2594607607C126322002 @default.
• W2594607607 hasConceptScore W2594607607C166888038 @default.
• W2594607607 hasConceptScore W2594607607C177713679 @default.
• W2594607607 hasConceptScore W2594607607C2775992322 @default.
• W2594607607 hasConceptScore W2594607607C2776315533 @default.
• W2594607607 hasConceptScore W2594607607C2777058267 @default.
• W2594607607 hasConceptScore W2594607607C2777637488 @default.
• W2594607607 hasConceptScore W2594607607C2778897966 @default.
• W2594607607 hasConceptScore W2594607607C2908647359 @default.
• W2594607607 hasConceptScore W2594607607C501593827 @default.
• W2594607607 hasConceptScore W2594607607C523546767 @default.
• W2594607607 hasConceptScore W2594607607C535046627 @default.
• W2594607607 hasConceptScore W2594607607C54355233 @default.
• W2594607607 hasConceptScore W2594607607C547475151 @default.

• next